John G Ullman & Associates Inc. lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 50.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 910 shares of the biopharmaceutical company’s stock after selling 920 shares during the […]